Moreno, V., Gil-Martin, M., Johnson, M. L., Aljumaily, R., Lopez Criado, P., Northfelt, D. W., Crittenden, M., Jabbour, S., Rosen, L., Garrido, P., Hervás Morón, A., Rietschel, P., Mohan, K. K., Li, J., Stankevich, E., Feng, M., Lowy, I., & Fury, M. G. (n.d.). 72PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100097076887.0x000038